INS and diabetes mellitus: The Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction 2 (DIGAMI-2) trial comprised 1253 patients of whom 947 were randomly assigned to insulin-based or conventional glucose control at hospital discharge after receiving 24 h of insulin–glucose infusion in hospital.